Mary Struthers

Person

Edison, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,926,673
- Issue date Mar 12, 2024
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,795,231
- Issue date Oct 24, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,773,178
- Issue date Oct 3, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding antagonistic CD40 monoclonal antibodies
- Patent number 11,613,585
- Issue date Mar 28, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-2/Interleukin-2 receptor alpha fusion proteins and meth...
- Patent number 11,359,000
- Issue date Jun 14, 2022
- Bristol-Myers Squibb Company
- Mary Struthers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,261,258
- Issue date Mar 1, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses in treating immune...
- Patent number 11,254,750
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40...
- Patent number 11,220,550
- Issue date Jan 11, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...
- Patent number 10,787,494
- Issue date Sep 29, 2020
- Bristol-Myers Squibb Company
- Mary Struthers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FUSION PROTEINS FOR THE TREATMENT OF DISEASE
- Publication number 20240325495
- Publication date Oct 3, 2024
- Bristol-Myers Squibb Company
- Alice L. WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240239909
- Publication date Jul 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240124597
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method of Treating an Autoimmune Disease with Antagonistic CD40 Mon...
- Publication number 20230331860
- Publication date Oct 19, 2023
- Bristol-Myers Squibb Company
- Ying Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20230322941
- Publication date Oct 12, 2023
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody Variants with Improved Pharmacokinetic Properties
- Publication number 20230203177
- Publication date Jun 29, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...
- Publication number 20220348625
- Publication date Nov 3, 2022
- Bristol-Myers Squibb Company
- Mary STRUTHERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220177596
- Publication date Jun 9, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220169742
- Publication date Jun 2, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220153856
- Publication date May 19, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220144962
- Publication date May 12, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20210054090
- Publication date Feb 25, 2021
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20200157233
- Publication date May 21, 2020
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THER...
- Publication number 20200148779
- Publication date May 14, 2020
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...
- Publication number 20190359672
- Publication date Nov 28, 2019
- Bristol-Myers Squibb Company
- Mary STRUTHERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...
- Publication number 20190300592
- Publication date Oct 3, 2019
- Bristol-Myers Squibb Company
- Mary STRUTHERS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20180340031
- Publication date Nov 29, 2018
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators o...
- Publication number 20060030582
- Publication date Feb 9, 2006
- Julie DeMartino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mary Struthers

Person

Patents Grantslast 30 patents

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses thereof

Nucleic acids encoding antagonistic CD40 monoclonal antibodies

Interleukin-2/Interleukin-2 receptor alpha fusion proteins and meth...

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses in treating immune...

Antagonistic anti-CD40 antibodies and methods of antagonizing CD40...

Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...

Patents Applicationslast 30 patents

FUSION PROTEINS FOR THE TREATMENT OF DISEASE

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Method of Treating an Autoimmune Disease with Antagonistic CD40 Mon...

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Antibody Variants with Improved Pharmacokinetic Properties

INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THER...

INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...

INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators o...